Presence of Cardiomyopathy in DLBCL Drives Treatment Decisions
Physician's Weekly
JUNE 16, 2025
The survey presented two patient vignettes and analyzed the respondents’ preferred treatment choices for patients with cardiac risk, use of cardioprotective strategies, post-treatment surveillance, and willingness to participate in clinical trials. She has no cardiopulmonary symptoms, ECOG PS 0, and no other comorbidities.”
Let's personalize your content